PRMT7-Mediated PTEN Activation Enhances Bone Regeneration in Female Mice

Area of Science:

• Epigenetics
• Bone Biology
• Regenerative Medicine

Background:

• Epigenetic regulation is crucial for osteogenic differentiation, but specific mechanisms remain unclear.
• Identifying novel epigenetic regulators can lead to new treatments for bone diseases.

Purpose of the Study:

• To identify novel epigenetic regulators involved in mesenchymal stem cells (MSCs) osteogenic commitment.
• To elucidate the molecular mechanisms by which PRMT7 regulates osteogenesis and bone regeneration.

Main Methods:

• Conditional knockout of Prmt7 in mice.
• Analysis of osteogenesis and bone regeneration in femurs and mandibles.
• Investigation of PRMT7's effect on PTEN transcription and protein stability.
• Assessment of H3R2me1 levels at the PTEN promoter.

Main Results:

• Conditional knockout of Prmt7 significantly impaired osteogenesis and bone regeneration in female mice.
• PRMT7 activates PTEN transcription by increasing H3R2me1 at the PTEN promoter and stabilizes nuclear PTEN.
• Overexpression of PTEN rescued the osteogenic deficits in Prmt7-deficient mice.

Conclusions:

• PRMT7 is a novel epigenetic regulator essential for MSCs osteogenic commitment and bone regeneration, particularly in females.
• The PRMT7-PTEN axis represents an unprecedented regulatory pathway in bone biology.
• PRMT7 is a potential therapeutic target for promoting bone formation and regeneration.